132 related articles for article (PubMed ID: 34814099)
21. Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia.
Wu LY; Cheah IK; Chong JR; Chai YL; Tan JY; Hilal S; Vrooman H; Chen CP; Halliwell B; Lai MKP
Free Radic Biol Med; 2021 Dec; 177():201-211. PubMed ID: 34673145
[TBL] [Abstract][Full Text] [Related]
22. An Assessment of the Relationship between Structural and Functional Imaging of Cerebrovascular Disease and Cognition-Related Fibers.
Tang X; Xiao X; Yin J; Yang T; Zeng B
Comput Math Methods Med; 2020; 2020():4347676. PubMed ID: 32411283
[TBL] [Abstract][Full Text] [Related]
23. Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
Delgado C; Vergara RC; Martínez M; Musa G; Henríquez F; Slachevsky A
J Alzheimers Dis; 2019; 67(1):381-392. PubMed ID: 30584142
[TBL] [Abstract][Full Text] [Related]
24. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
[TBL] [Abstract][Full Text] [Related]
25. Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.
Piriz A; Reyes D; Narkhede A; Guzman VA; Viqar F; Meier IB; Budge M; Mena P; Dashnaw S; Lee J; Reitz C; Gutierrez J; Campos L; Medrano M; Lantigua R; Mayeux R; Brickman AM
J Alzheimers Dis; 2018; 66(4):1519-1528. PubMed ID: 30412503
[TBL] [Abstract][Full Text] [Related]
26. Long-term neurobehavioral correlates of brain cortical microinfarcts in a memory clinic cohort in Singapore.
Xu X; Ni Kan C; Li-Hsian Chen C; Hilal S
Int J Stroke; 2022 Feb; 17(2):218-225. PubMed ID: 33724091
[TBL] [Abstract][Full Text] [Related]
27. Association of Magnetic Resonance Imaging Markers of Cerebrovascular Disease Burden and Cognition.
Xu X; Hilal S; Collinson SL; Chong EJ; Ikram MK; Venketasubramanian N; Chen CL
Stroke; 2015 Oct; 46(10):2808-14. PubMed ID: 26330446
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.
Aalten P; Verhey FR; Boziki M; Bullock R; Byrne EJ; Camus V; Caputo M; Collins D; De Deyn PP; Elina K; Frisoni G; Girtler N; Holmes C; Hurt C; Marriott A; Mecocci P; Nobili F; Ousset PJ; Reynish E; Salmon E; Tsolaki M; Vellas B; Robert PH
Dement Geriatr Cogn Disord; 2007; 24(6):457-63. PubMed ID: 17986816
[TBL] [Abstract][Full Text] [Related]
29. The Effects of Mean of Visit-to-Visit Blood Pressure on Incident Brain Vascular Lesions and Functional-Cognitive Decline.
Gyanwali B; Cai CXT; Chen C; Vrooman H; Tan CS; Hilal S
J Alzheimers Dis; 2021; 82(2):561-573. PubMed ID: 34057087
[TBL] [Abstract][Full Text] [Related]
30. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.
Yassi N; Hilal S; Xia Y; Lim YY; Watson R; Kuijf H; Fowler C; Yates P; Maruff P; Martins R; Ames D; Chen C; Rowe CC; Villemagne VL; Salvado O; Desmond PM; Masters CL
J Alzheimers Dis; 2020; 73(3):897-907. PubMed ID: 31884485
[TBL] [Abstract][Full Text] [Related]
31. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.
Aalten P; Verhey FR; Boziki M; Brugnolo A; Bullock R; Byrne EJ; Camus V; Caputo M; Collins D; De Deyn PP; Elina K; Frisoni G; Holmes C; Hurt C; Marriott A; Mecocci P; Nobili F; Ousset PJ; Reynish E; Salmon E; Tsolaki M; Vellas B; Robert PH
Dement Geriatr Cogn Disord; 2008; 25(1):1-8. PubMed ID: 18025783
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
Otoki Y; Yu D; Shen Q; Sahlas DJ; Ramirez J; Gao F; Masellis M; Swartz RH; Chan PC; Pettersen JA; Kato S; Nakagawa K; Black SE; Swardfager W; Taha AY
J Alzheimers Dis; 2023; 93(2):665-682. PubMed ID: 37092220
[TBL] [Abstract][Full Text] [Related]
33. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.
DeCarli C; Mungas D; Harvey D; Reed B; Weiner M; Chui H; Jagust W
Neurology; 2004 Jul; 63(2):220-7. PubMed ID: 15277612
[TBL] [Abstract][Full Text] [Related]
34. Impact of cerebrovascular pathology on behavioural and neuropsychiatric symptoms in patients with Alzheimer's dementia: findings from a retrospective, naturalistic study.
Klugman A; Marshall J; Tabet N
Int J Clin Pract; 2009 Jul; 63(7):1024-30. PubMed ID: 19570120
[TBL] [Abstract][Full Text] [Related]
35. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
36. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
Dickie DA; Quinn TJ; Dawson J
Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
[TBL] [Abstract][Full Text] [Related]
37. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
[TBL] [Abstract][Full Text] [Related]
38. Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change.
Reus LM; Vijverberg EG; Tijms BM; Kate MT; Gossink F; Krudop WA; Campo MD; Teunissen CE; Barkhof F; van der Flier WM; Visser PJ; Dols A; Pijnenburg YA
J Psychiatr Res; 2018 Sep; 104():183-191. PubMed ID: 30103065
[TBL] [Abstract][Full Text] [Related]
39. MRI Markers of Mixed Pathology and Cognitive Impairment in Multiethnic Asians.
Tan CH; Hilal S; Xu X; Vrooman H; Cheng CY; Wong TY; Venketasubramanian N; Chen C
J Alzheimers Dis; 2020; 73(4):1501-1509. PubMed ID: 31958085
[TBL] [Abstract][Full Text] [Related]
40. Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort.
Chia RSL; Minta K; Wu LY; Salai KHT; Chai YL; Hilal S; Venketasubramanian N; Chen CP; Chong JR; Lai MKP
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
